Belinda Howe, RN, BAppSc, MpH, is a senior project manager at the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University. She is a past executive committee member of the Australian and New Zealand Intensive Care Society Clinical Trials Group. Her expertise is in managing large, international clinical trials, particularly in septic shock and sedation in critical care. Her areas of interest are clinical trial governance, methodology and consent in the critically ill. She is currently the project manager for the ARISE FLUIDS randomised trial, the largest Australasian clinical trial evaluating a restrictive fluid strategy for early septic shock.

Twitter:  @howe_belinda

Stephen Macdonald is an Emergency Physician and Clinical Associate Professor at the University of Western Australia Medical School. He is a Senior Research Fellow at the Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research, and an Adjunct Senior Research Fellow in Critical Care at Monash University. He completed his PhD investigating the microcirculation in early septic shock. His research encompasses preclinical studies and bedside research in the emergency department. Stephen is Co-Chief Investigator of the ARISE FLUIDS trial, the largest Australasian clinical trial comparing early vasopressors to intravenous fluids in the initial resuscitation of septic shock. He is a past Chair of the Australasian College for Emergency Medicine Clinical Trials Network. The Global Sepsis Alliance has recognised Stephen for his research and advocacy work. In 2019, he was awarded a Churchill Fellowship to investigate best-practice sepsis care in the USA, Canada, and the UK.

Professor Carol Hodgson is a clinical trialist with expertise in long-term functional outcomes after critical illness. She is Head of the Division of Clinical Trials and Cohort Studies in the School of Public Health and Preventive Medicine, and Co-Director of the Australian and New Zealand Intensive Care Research Centre, Monash University. She is Chair of the Australian Health Research Alliance and the Executive Director of Monash Partners Research Translation Network, which aims to ensure research is implemented and translated into healthcare to improve patient outcomes. She sits on the Australian NHMRC Research Committee which fosters research across the spectrum of health and medical research, including the awarding of grants and providing research support. She has worked in ICU at Alfred Health for over 25 years as a Specialist Physiotherapist.

Paul Young’s primary research interest is in the design and conduct of large-scale multicentre randomised clinical trials in the field of Intensive Care Medicine. An active member of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), Paul is a leading member of the international intensive care research community.

Alongside his role at the MRINZ, Paul is the Medical Director of the Wakefield Hospital ICU and co-clinical leader of the Intensive Care Research Unit at Wellington Hospital. Paul is Clinical Associate Professor, Department of Critical Care, at the University of Melbourne, an Adjunct Professor at the Australian and New Zealand Intensive Care Research Centre, Monash University, and the acting co Editor-in-Chief for Critical Care and Resuscitation, the highest impact journal in the field of Intensive Care Medicine outside the US and Europe.

Involved in research collaborations with colleagues worldwide, Paul has published over 250 peer-reviewed journal articles, including numerous high impact publications in the New England Journal of Medicine, the Lancet, and the Journal of the American Medical Association.

Twitter: @DogICUma

Bronwen Connolly is a Professor of Critical Care at Queen’s University Belfast, where she is Deputy Director of the Wellcome-Wolfson Institute for Experimental Medicine, and Honorary Senior Fellow at The University of Melbourne, with over 25 years’ experience as a physiotherapist. Her research interests focus on acute respiratory and rehabilitation interventions in critical illness, the recovery, long-term outcome, and survivorship of post critical illness patients, and clinical trial methods. Bronwen is currently Co-Chief Investigator of the MARCH trial, investigating the effectiveness of mucoactive drugs, as well as co-Investigator on iRehab and several of the CoReCCT Confederation trials (all NIHR HTA Programme-funded). She also leads PRACTICE, focusing on the development of a core outcome set for trials of physical rehabilitation in critical illness. As of July 2026, Bronwen will commence tenure on the NIHR HTA Clinical Evaluations and Trials Funding Committee. Within the critical care community, her roles include ICS Director of Research and Chair of the UK Critical Care Research Group.

Adriano Pereira is a Brazilian physician and healthcare innovator who serves as Coordinator of the Telemedicine Department at Hospital Israelita Albert Einstein in São Paulo, Brazil. In this role, he leads the strategic development and operational delivery of one of Latin America’s most advanced telehealth programmes, integrating digital technologies into acute, ambulatory, and critical care services. His work focuses on scaling high-quality remote care, ensuring clinical governance, and embedding evidence-based protocols within virtual models of healthcare delivery.

At Hospital Israelita Albert Einstein, Dr Pereira has been instrumental in expanding tele-ICU capabilities, remote specialist consultations, and digital health infrastructure to support hospitals and health systems across Brazil. His interests include the optimisation of telemedicine workflows, quality assurance in virtual care, and the use of data analytics to enhance patient safety and system performance. Through clinical leadership and innovation, he contributes to shaping more connected, accessible, and resilient healthcare systems.

Régis Rosa is a Brazilian critical care physician and clinical researcher whose work centres on improving outcomes for patients across the continuum of acute and post-acute illness. He serves as Head of the Internal Medicine Department at Hospital Moinhos de Vento and is Professor of Critical Care Medicine at the Federal University of Rio Grande do Sul. In these roles, he combines senior clinical leadership with academic scholarship, fostering the integration of rigorous research methods into everyday intensive care practice.

Dr Rosa is an active member of the Scientific Committee of the Brazilian Research in Intensive Care Network (BRICNet), contributing to national and international collaborative studies. His research programme focuses on post-ICU care, survivorship, and the organisation of critical care systems, with particular interest in how structural and process-of-care factors influence long-term patient outcomes. Through both clinical leadership and multicentre research, he seeks to advance a more patient-centred, system-aware model of intensive care delivery.

Fernando Zampieri is an Assistant Professor of Medicine at the University of Alberta in Edmonton, Canada, and an attending physician in both the General Systems ICU and the Neurosciences ICU at University of Alberta Hospital. A clinician–scientist with a strong focus on critical care medicine, his work bridges frontline intensive care practice with rigorous clinical research, particularly in the design, conduct, and interpretation of randomized controlled trials in acute illness. He is widely recognised for his methodological expertise and his commitment to advancing evidence-based care for critically ill patients.

Prior to relocating to Canada, Dr Zampieri was a researcher at the Academic Research Organization of Hospital Israelita Albert Einstein in São Paulo, Brazil, one of Latin America’s leading centres for clinical investigation. There, he contributed to high-impact multicentre trials and developed a reputation for thoughtful, data-driven scholarship. Across his academic career, he has combined international collaboration with a deep interest in improving trial methodology and translating robust evidence into meaningful improvements in patient outcomes.

Kristin Mayes, MS, serves as Senior Program Administrator at the UPMC Center for High-Value Health Care, a non-profit research organization, in Pittsburgh, Pennsylvania, USA. She brings over a decade of experience in designing, implementing, and evaluating research initiatives that advance healthcare access, equity, and patient-centered outcomes. Kristin leads and supports comparative effectiveness trials and uses implementation science methods within complex healthcare systems, driving evidence-based strategies to improve care delivery and outcomes.

Dr. Sachin Yende is a distinguished clinician-scientist and a nationally recognized authority on the long-term outcomes of sepsis. Currently serving as Professor and formerly Vice-Chair in the Department of Critical Care Medicine at the University of Pittsburgh, Dr. Yende’s research focuses on the intersection of acute critical illness and longitudinal recovery. His work has shaped the medical community’s understanding of how sepsis affects patients well beyond their initial hospital discharge.

Dr. Yende has published over 100 peer-reviewed papers, editorials, and book chapters. His research is frequently featured in prestigious medical journals, including the New England Journal of Medicine and JAMA. His ongoing research program is supported by consistent funding from the National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute (PCORI).

Beyond his academic contributions, Dr. Yende serves as the Chief Medical Officer for Integrated Veteran Care (IVC) at the Department of Veterans Affairs. In this capacity, he leads national efforts to enhance healthcare access and quality for millions of Veterans. By blending his deep expertise in clinical research with high-level operational leadership, he ensures that the latest scientific advancements are translated into improved care delivery and better outcomes for beneficiaries across the United States.

Tim Walsh is Professor of Critical Care at the University of Edinburgh and Honorary Consultant in Critical Care at Edinburgh Royal Infirmary. He is Head of the Academic Dept of Anaesthesia, Critical Care, and Pain Medicine in the University of Edinburgh, and Co-director of Acute Care Edinburgh a multidisciplinary research grouping in the University of Edinburgh Usher Institute. He is also Associate Dean for Clinical Research Delivery in the College of Medicine and Veterinary Medicine, University of Edinburgh.

Tim leads a multidisciplinary clinical research group with interests including transfusion medicine, sedation in the critically ill, recovery from critical illness and the epidemiology and prevention of ICU acquired infection. He has a particular interest in large pragmatic clinical trials, complex health intervention trials, and the evaluation of novel diagnostics and technologies in acute care. He is a past Chairman of the NIHR UK Critical Care Research Network and UK Critical Care Research Group, and Director of Research & Innovation for NHS Lothian.

Twitter:  @Ed_TimWalsh

Dr. Stoppe, a Professor of Anesthesiology and Intensive Care Medicine at Charité – Universitätsmedizin Berlin and Würzburg University in Germany, leads several international clinical trials in the field of clinical nutrition. He has established a global clinical research group dedicated to interventional nutrition studies in collaboration with partners worldwide.

The recipient of numerous research grants—including awards from the German Research Foundation (DFG) and other third-party funders—Dr. Stoppe’s research spans nutrition studies, perioperative optimization, functional outcomes and risk assessment, guideline development, translational research, and organ protection. His work focuses particularly on cardiac surgery, severe burns, and critically ill patients.

With more than 290 publications to his name, Dr. Stoppe is a frequent speaker at international conferences. He serves as Section Chair of the Feeding, Rehabilitation, Endocrinology & Metabolism section within the European Society of Intensive Care Medicine. Additionally, he contributes to and coordinates several European, American, German, and Canadian guideline initiatives and holds a position on the executive board of the ERAS Cardiac Society.

Twitter: @CStoppe

Dr. Rochwerg is an intensivist and researcher based at McMaster University in Hamilton, Canada. He leads multi-national randomized controlled trials in sepsis and acute hypoxemic respiratory failure. He is chair for the Internal Medicine Section at the Society of Critical Care Medicine and chair-elect for The Canadian Critical Care Trials Group. He is vice-chair for the international Surviving Sepsis Campaign, an Associate Editor at Critical Care Medicine and ACP Journal Club and serves on the editorial board at CHEST. In addition to this, he supports many national and international societies in developing clinical practice guidelines in the field of critical care.

Twitter: @Bram_Rochwerg

Lyvonne is a Professor of Critical Care Nursing at Edge Hill University and Alder Hey Children’s Hospital, Liverpool. She is an Associate Editor for Nursing in Critical Care and on the editorial board for Pediatric Critical Care Medicine and the Journal of Parental and Enteral Nutrition. She is an intensive care nurse with over 35 years’ experience in Australia and in the UK. She has over 170 peer reviewed publications and has held several NIHR research grants. She is currently the chief investigator for the multicentre trial of no routine gastric residual volume measurement to guide enteral feeding in critically ill children (GASTRIC-PICU). She is a member of the NIHR HTA International funding panel. Her research interests focus mainly on improving nutrition in critically ill children, particularly around enteral feeding, but she also focuses on respiratory critical care: making endotracheal suctioning safer, weaning mechanical ventilation, and preventing extubation failure. She is also committed to implementing research evidence into clinical practice. Her research takes an ‘critical care across the lifespan’ approach with work in neonatal, paediatric, and adult intensive care. She is a visiting professor for the School of Health Sciences in Geneva. She was previously the Nursing president for the European Society of Pediatric and Neonatal Intensive Care (RSPNIC) and is the elected deputy chair for the Paediatric Critical Care Society Study Group (PCCS-SG) and a member of the NIHR PCCS Research Incubator.

Twitter:  @lyvonnetume

Lars Wiuff Andersen is a clinician and professor with a focus on acute and critical care, with a primary interest in cardiac arrest. His research includes animal studies, large observational studies, and randomised clinical trials to test treatments and hopefully improve outcomes.

Twitter:  @LarsWAndersen1

Asger Granfeldt a professor specializing in intensive care, with a particular focus on cardiac arrest research. His primary interest lies in utilizing experimental animal models to enhance our understanding of cardiac arrest pathophysiology and to evaluate novel treatments before they progress to clinical trials. Additionally, he is actively participating in several clinical trials related to cardiac arrest.

Twitter: @AsgerGranfeldt

Tine Sylvest Meyhoff (MD, PhD) is a postdoctoral researcher at the Department of Intensive Care, Rigshospitalet, University of Copenhagen. Experienced medical researcher in randomised clinical trials and trial methodology. She is part of the core team behind the adaptive intensive care platform trial, INCEPT, and a board member of the collaboration for research in intensive care (CRIC) network. Principal investigator for the CLASSIC trial and the current albumin domain on INCEPT. 

Tim Walsh is Professor of Critical Care at the University of Edinburgh and Honorary Consultant in Critical Care at Edinburgh Royal Infirmary. He is Head of the Academic Dept of Anaesthesia, Critical Care, and Pain Medicine in the University of Edinburgh, and Co-director of Acute Care Edinburgh a multidisciplinary research grouping in the University of Edinburgh Usher Institute. He is also Associate Dean for Clinical Research Delivery in the College of Medicine and Veterinary Medicine, University of Edinburgh.

Tim leads a multidisciplinary clinical research group with interests including transfusion medicine, sedation in the critically ill, recovery from critical illness and the epidemiology and prevention of ICU acquired infection. He has a particular interest in large pragmatic clinical trials, complex health intervention trials, and the evaluation of novel diagnostics and technologies in acute care. He is a past Chairman of the NIHR UK Critical Care Research Network and UK Critical Care Research Group, and Director of Research & Innovation for NHS Lothian.

Twitter:  @Ed_TimWalsh

Paul Young’s primary research interest is in the design and conduct of large-scale multicentre randomised clinical trials in the field of Intensive Care Medicine. An active member of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), Paul is a leading member of the international intensive care research community.

Alongside his role at the MRINZ, Paul is the Medical Director of the Wakefield Hospital ICU and co-clinical leader of the Intensive Care Research Unit at Wellington Hospital. Paul is Clinical Associate Professor, Department of Critical Care, at the University of Melbourne, an Adjunct Professor at the Australian and New Zealand Intensive Care Research Centre, Monash University, and the acting co Editor-in-Chief for Critical Care and Resuscitation, the highest impact journal in the field of Intensive Care Medicine outside the US and Europe.

Involved in research collaborations with colleagues worldwide, Paul has published over 250 peer-reviewed journal articles, including numerous high impact publications in the New England Journal of Medicine, the Lancet, and the Journal of the American Medical Association.

Twitter: @DogICUma

Niklas Nielsen is professor of anesthesiology and intensive care at Lund University, Sweden and vice dean of the Medical Faculty. He has during the last two decades been leading large international cardiac arrest studies and trials building a network of over 80 hospitals in 18 countries focusing on targeted temperature management for ischemic brain damage and prognostication of outcome.

The trials, TTM1 and TTM2, have had considerable impact on clinical guidelines worldwide for post cardiac arrest care, neuroprognostication and follow-up. He is now chief investigator for the STEPCARE project, a randomizied trial with 3500 participants looking into fever management, sedation strategies and level of mean arterial pressure after cardiac arrest.

He would love to sail to the Critical Care Reviews Belfast meeting.

Prof. Niall Ferguson is Professor in the Interdepartmental Division of Critical Care Medicine, Department of Medicine, at the University of Toronto, with cross-appointments in the Department of Physiology and the Institute of Health Policy, Management and Evaluation.  He is a practicing Intensivist and Clinician-Scientist at the University Health Network and is the Medical Director of the Toronto General Hospital Medical-Surgical ICU. He is a Senior Scientist in the Toronto General Research Institute and Director of the Toronto General Hospital Clinical Research Unit.

At a provincial level, Dr. Ferguson is Deputy chair of the Ontario Critical Care Command Centre.  Dr. Ferguson’s research, which is supported by national and international peer-reviewed grants, investigates treatments for patients with acute hypoxemic respiratory failure with a focus on clinical trials in mechanical ventilation and extra-corporeal life support.  He has published more than 300 papers listed on PubMed and his H-index is over 90.  Dr. Ferguson is the Chair for Critical Care Canada Forum, Canada’s national critical care conference. He is a frequent invited speaker at national and international meetings, having given over 400 such talks.

Twitter:  @nialldferguson

Professor Marlies Ostermann is a Consultant in Critical Care & Nephrology at Guy’s and St Thomas’ NHS Foundation Trust in London and a Professor in the Department of Critical Care at King’s College London, where she is widely recognised for her clinical, research and educational leadership in acute kidney injury, extracorporeal organ support and sepsis in critically ill patients. She combines her NHS practice with a strong academic profile, publishing extensively and mentoring clinicians and scientists in multidisciplinary critical care nephrology.

Internationally, she plays prominent roles in professional societies: she is Director of Research of the Intensive Care Society (ICS) in the UK and President-Elect of the European Society of Intensive Care Medicine (ESICM), as well as serving in leadership positions such as Deputy Chair of the AKI Working Group of ESICM and on key guideline and research committees. Through these roles she contributes to shaping clinical practice, research agendas and education in intensive care medicine across Europe and beyond.

Twitter:  @MarliesOst

Dr Kathryn Puxty, MBCHB (Hon), MD, is a Consultant in Anaesthesia and Intensive Care Medicine at Glasgow Royal Infirmary with broad clinical and research interests including long-term outcomes after critical illness, cancer and post-ICU survivorship, burns care and renal outcomes in critical care populations. She combines her NHS clinical work with academic roles and has contributed to multiple studies and reviews in areas such as burn shock resuscitation and intensive care outcomes.

In addition to her clinical duties, Dr Puxty is an Honorary Clinical Associate Professor at the University of Glasgow School of Medicine, Dentistry & Nursing, where she is involved in research supervision, education and collaborative projects. She also holds distinctions such as CSO/NRS Career Research Fellow and contributes to national and international critical care and anaesthesia research networks.

Twitter:  @KPuxty

Jo McPeake is Professor of Nursing at the University of Cambridge and Cambridge University Hospital’s NHS Foundation Trust. With a background in acute and critical care nursing, Professor McPeake leads a programme of research dedicated to improving the outcomes of critically ill patients and their family members. Her programme of research has a particular focus on how social inequalities influence healthcare access and outcomes. Characteristically using mixed methods approaches, Professor McPeake has experience of evaluating complex healthcare interventions in the acute care environment.

Brenda is a Professor in Physiotherapy at Ulster University in Northern Ireland. She leads research focused on the health and rehabilitation of people after critical Illness and people with respiratory conditions. She has expertise with a range of research methodologies and is involved in several multi-centre research programmes funded (each over £1million) by the NIHR.

Brenda is the lead for the Centre for Health and Rehabilitation Technologies (CHaRT) School of Health Sciences, Ulster University, completing research in collaboration with local hospitals, and national and international colleagues, and she has key roles in Northern Ireland (NI) research infrastructure e.g. Clinical Research Facility (NICRF) Management Group.

She is a member of several professional bodies that support advancing education and research in respiratory health and recovery after critical illness and is an Associate Editor for Physiotherapy Canada. She has successfully supervised PhD students, MSc students, and research staff (> 50) and published widely (h-index 21). Recent achievements include winner of the Advancing Healthcare Awards Northern Ireland: Award for Research and Development (2023) and was recent president of the International Confederation of Cardiorespiratory Physiotherapists (2019-2023), World Physiotherapy.

Ary Serpa Neto, MD, MSc, PhD is an Intensivist and Director of Intensive Care Research at Austin Hospital in Melbourne, Australia. He is also an Associate Professor at the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, where he leads the Mechanical Ventilation and Renal & Metabolic Programs. He is a founding member of the Protective Ventilation Network (PROVENet) and a member of the Scientific Committee of the Brazilian Research in Intensive Care Network (BRICNet). His research focuses on mechanical ventilation, renal and metabolic care, and advanced clinical trial methodology, with a strong emphasis on translating evidence into clinical practice.

Ary has authored over 430 publications, including multiple articles in The New England Journal of Medicine, JAMA, and The Lancet Respiratory Medicine, and his work has been cited in several international guidelines. He currently leads several large-scale international randomised clinical trials in Australia, including the NHMRC-funded SODa-BIC, DRIVE and GuARDS trials.

Twitter:  @a_serpaneto

Srinivas Murthy is an academic pediatric intensive care physician and clinical researcher at the University of British Columbia in Vancouver, Canada. His academic and clinical interests are in the management of severe infections, global health, and innovative methods in clinical research. 

Twitter:  @srinmurthy99

Dr Turgeon is Professor and Director of Research in the Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, Québec, Canada. He is a scientist at the CHU de Québec-Université Laval Research Center and practices critical care medicine at l’Hôpital de l’Enfant-Jésus of the CHU de Québec-Université Laval. He leads extensive collaborative research programs in neurocritical care medicine including BRAINapt, a newly funded international platform trial in critically ill patients with traumatic brain injury (TBI).

In the last years, he led the HEMOTION trial, a multicenter international trial on red blood cell transfusion thresholds in TBI. His research is funded by the Canadian Institutes of Health Research (CIHR). Dr Turgeon is the chairholder of the Canada Research Chair in Critical Care Neurology and Trauma.

Twitter:  @AlexisTurgeon_

Marion Campbell is Vice-Principal (Research) for the University of Aberdeen and Professor of Health Services Research in the Health Services Research Unit (HSRU).   Marion is a medical statistician and clinical trialist. Her main research interests are in the design, conduct and analysis of clinical trials, especially complex trial design and the design and conduct of surgical and device trials.  She has published widely on clinical trials methodology, including on cluster randomised trials, design of trials of non-pharmacological interventions, pragmatic trials and trials reporting.  She has served on many national and international funding agencies and committees and is an elected Fellow of the Royal Society of Edinburgh, the Faculty of Public Health and the International Society for Clinical Trials.

Marion graduated with an honours degree in Statistics from the University of Aberdeen and subsequently gained an MSc in Statistics and PhD in Public Health.  Following early career appointments within the National Health Service in the fields of Operational Research and Statistics of Medical Audit, she joined the Health Services Research Unit in 1993.  She became Director of the Unit in 2007 - a position she held until the end of 2015, when she became Dean of Research for Life Sciences and Medicine.  She took up the role of Vice-Principal (Research) in October 2017.  HSRU remains her academic base.

Twitter:  @MarionKCampbell

Victoria Cornelius is a Professor in Medical Statistics and Trial Methodology and Director of Imperial Clinical Trials Unit. Her work in trials includes evaluating drug and complex interventions developing approaches that promote statistical efficiency in both Bayesian and frequentist frameworks. Her statistical methods research is in the use of time-to-event signal detection methods to identify adverse drug reactions, and co-leads the NIHR MRC TMRP specialist research group to improve the analysis of harm outcomes in randomised controlled trials.

Twitter:  @VR_Cornelius

Prof David Harrison graduated from the University of Cambridge with an MA in mathematics and a PhD in mathematical modelling of disease progression. He has worked for ICNARC since 2002. David is a Fellow of the Royal Statistical Society and an Honorary Professor in the Medical Statistics Unit of the London School of Hygiene & Tropical Medicine.

Twitter: @DavidHarrison80